Pub Date : 2025-05-02DOI: 10.18295/squmj.10.2024.063
Amira M Taha, Wesam A Moawad, Sara A A Saed, Tala J Alhejazi, Youstina A Sabri, Mohamed Abd-ElGawad, Juan L Alcazar, Nihal Al Riyami, Ayatallah Khafagy, Yasmine A Mohammed, Ahmed H Saad
This review aimed to assess diagnostic accuracy of transabdominal ultrasonography (TAS) sliding sign in diagnosing severe intra-abdominal adhesions with repeated Caesarean delivery (CD). PubMed, Google Scholar, Web of Science and Scopus were searched for published studies until October 2022. Studies evaluating the sliding sign as a predictor of intra-abdominal adhesions after repeat CD were included. STATA and Comprehensive Meta-Analysis for meta-analysis was used. A total of 7 studies (1,318 patients) were included. For identifying severe intra-abdominal adhesions, sliding sign on TAS had a combined sensitivity (64%, 95% confidence interval [CI]: 55-71%), specificity (93%, 95% CI: 89-96%), positive likelihood ratio (9.5, 95% CI: 5.7-16), negative likelihood ratio (0.39, 95% CI: 0.31-0.49) and diagnostic odds ratio (24, 95% CI: 13-46). Prediction intervals for sensitivity and specificity were 0.444-0.786 and 0.711-0.985, respectively. Sliding sign on TAS is a simple, non-invasive, good negative and practical method to exclude severe intra-abdominal adhesions involving the uterus with low sensitivity and high specificity.
本综述旨在评估经腹超声(TAS)滑动征象对反复剖宫产(CD)严重腹内粘连的诊断准确性。PubMed, b谷歌Scholar, Web of Science和Scopus检索了截至2022年10月的已发表研究。评估滑动征象作为重复CD后腹内粘连预测因子的研究被纳入。meta分析采用STATA和综合meta分析。共纳入7项研究(1318例患者)。对于识别严重腹内粘连,TAS滑动征象具有综合敏感性(64%,95%可信区间[CI]: 55-71%)、特异性(93%,95% CI: 89-96%)、阳性似然比(9.5,95% CI: 5.7-16)、阴性似然比(0.39,95% CI: 0.31-0.49)和诊断优势比(24,95% CI: 13-46)。敏感性预测区间为0.444 ~ 0.786,特异性预测区间为0.711 ~ 0.985。TAS滑动征象是一种简单、无创、阴性效果好、实用的排除严重腹腔内粘连累及子宫的方法,敏感性低,特异性高。
{"title":"Diagnostic Accuracy of Abdominal Ultrasonographic Sliding Sign in the Evaluation of Severe Intra-Abdominal Adhesions Involving the Uterus in Women Undergoing Repeat Caesarean Delivery: <i>Systematic review and meta-analysis</i>.","authors":"Amira M Taha, Wesam A Moawad, Sara A A Saed, Tala J Alhejazi, Youstina A Sabri, Mohamed Abd-ElGawad, Juan L Alcazar, Nihal Al Riyami, Ayatallah Khafagy, Yasmine A Mohammed, Ahmed H Saad","doi":"10.18295/squmj.10.2024.063","DOIUrl":"10.18295/squmj.10.2024.063","url":null,"abstract":"<p><p>This review aimed to assess diagnostic accuracy of transabdominal ultrasonography (TAS) sliding sign in diagnosing severe intra-abdominal adhesions with repeated Caesarean delivery (CD). PubMed, Google Scholar, Web of Science and Scopus were searched for published studies until October 2022. Studies evaluating the sliding sign as a predictor of intra-abdominal adhesions after repeat CD were included. STATA and Comprehensive Meta-Analysis for meta-analysis was used. A total of 7 studies (1,318 patients) were included. For identifying severe intra-abdominal adhesions, sliding sign on TAS had a combined sensitivity (64%, 95% confidence interval [CI]: 55-71%), specificity (93%, 95% CI: 89-96%), positive likelihood ratio (9.5, 95% CI: 5.7-16), negative likelihood ratio (0.39, 95% CI: 0.31-0.49) and diagnostic odds ratio (24, 95% CI: 13-46). Prediction intervals for sensitivity and specificity were 0.444-0.786 and 0.711-0.985, respectively. Sliding sign on TAS is a simple, non-invasive, good negative and practical method to exclude severe intra-abdominal adhesions involving the uterus with low sensitivity and high specificity.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"29-37"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244295/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-02eCollection Date: 2025-01-01DOI: 10.18295/2075-0528.2891
Hussain A Al-Lawati, Khalid Al Baimani, Mohammed N Al Rawahi
Objectives: Anthracyclines are widely used in the treatment of breast cancer. One of the known adverse effects of anthracyclines is anthracycline-induced cardiomyopathy. Studies done worldwide showed that the prevalence of chemotherapy-induced cardiomyopathy is approximately 9%. However, studies evaluating this complication prevalence, risk factors and cumulative dose are lacking in Oman. This study aimed to investigate the prevalence of anthracycline-induced cardiomyopathy among breast cancer patients in Oman.
Methods: This retrospective study included all breast cancer patients who received anthracycline-based chemotherapy exclusively between September 2008 and December 2020 at Sultan Qaboos University Hospital in Muscat. Patients with partial treatment, coexisting heart failure and who did not receive anthracycline as part of the chemotherapy regimen were excluded. Chemotherapy-induced cardiomyopathy was defined as a drop of left ventricular ejection fraction >10% from the patient's baseline during or after receiving anthracycline-based chemotherapy.
Results: A total of 385 patients were included in this study of which 39 (10.1%) developed cardiomyopathy after exposure to anthracyclines. The mean cumulative dose of doxorubicin among these patients was 239 mg/m2 (epirubicin was converted to doxorubicin equivalent dose). Univariate analysis showed that the risk of anthracycline-induced cardiomyopathy was influenced by cardiovascular risk factors such as hypertension (33.3%), diabetes (25.6%), dyslipidaemia (20.5%) and previous cardiovascular medications use (10.3%). Trastuzumab exposure significantly correlated with an increased risk of developing cardiomyopathy (P < 0.001). However, multivariate analysis did not show any significant association.
Conclusions: Anthracycline-induced cardiomyopathy was influenced by various cardiovascular risk factors as well as trastuzumab exposure. Further studies are recommended to investigate the prevention and management of anthracycline-induced cardiomyopathy.
{"title":"Anthracycline-Induced Cardiomyopathy in Breast Cancer Patients in Oman: <i>A retrospective study</i>.","authors":"Hussain A Al-Lawati, Khalid Al Baimani, Mohammed N Al Rawahi","doi":"10.18295/2075-0528.2891","DOIUrl":"10.18295/2075-0528.2891","url":null,"abstract":"<p><strong>Objectives: </strong>Anthracyclines are widely used in the treatment of breast cancer. One of the known adverse effects of anthracyclines is anthracycline-induced cardiomyopathy. Studies done worldwide showed that the prevalence of chemotherapy-induced cardiomyopathy is approximately 9%. However, studies evaluating this complication prevalence, risk factors and cumulative dose are lacking in Oman. This study aimed to investigate the prevalence of anthracycline-induced cardiomyopathy among breast cancer patients in Oman.</p><p><strong>Methods: </strong>This retrospective study included all breast cancer patients who received anthracycline-based chemotherapy exclusively between September 2008 and December 2020 at Sultan Qaboos University Hospital in Muscat. Patients with partial treatment, coexisting heart failure and who did not receive anthracycline as part of the chemotherapy regimen were excluded. Chemotherapy-induced cardiomyopathy was defined as a drop of left ventricular ejection fraction >10% from the patient's baseline during or after receiving anthracycline-based chemotherapy.</p><p><strong>Results: </strong>A total of 385 patients were included in this study of which 39 (10.1%) developed cardiomyopathy after exposure to anthracyclines. The mean cumulative dose of doxorubicin among these patients was 239 mg/m<sup>2</sup> (epirubicin was converted to doxorubicin equivalent dose). Univariate analysis showed that the risk of anthracycline-induced cardiomyopathy was influenced by cardiovascular risk factors such as hypertension (33.3%), diabetes (25.6%), dyslipidaemia (20.5%) and previous cardiovascular medications use (10.3%). Trastuzumab exposure significantly correlated with an increased risk of developing cardiomyopathy (<i>P</i> < 0.001). However, multivariate analysis did not show any significant association.</p><p><strong>Conclusions: </strong>Anthracycline-induced cardiomyopathy was influenced by various cardiovascular risk factors as well as trastuzumab exposure. Further studies are recommended to investigate the prevention and management of anthracycline-induced cardiomyopathy.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"839-846"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12538945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145347487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Deciduosis is a benign condition characterised by the transformation of subepithelial connective tissue into decidual-like cells, typically occurring in response to hormonal changes during pregnancy. Although benign, cervical deciduosis may macroscopically resemble malignant lesions, leading to diagnostic uncertainty. This report presents two cases of cervical deciduosis diagnosed in early pregnancy. Both patients presented with first-trimester vaginal bleeding, and speculum examination revealed extensive wart-like lesions covering the cervix. Histopathological examination of cervical biopsies confirmed decidual changes. In pregnant women presenting with threatened miscarriage, a thorough local examination and biopsy of atypical cervical lesions are essential to exclude malignancy. As cervical deciduosis is a benign and self-limiting condition, no further treatment is usually required.
{"title":"Cervical Deciduosis in Early Pregnancy Mimicking Malignancy: <i>A report of two cases</i>.","authors":"Ajit Sebastian, Nada Salih, Shiby Jose, Tamima Al Dughaishi, Vaidyanathan Gowri","doi":"10.18295/2075-0528.2870","DOIUrl":"10.18295/2075-0528.2870","url":null,"abstract":"<p><p>Deciduosis is a benign condition characterised by the transformation of subepithelial connective tissue into decidual-like cells, typically occurring in response to hormonal changes during pregnancy. Although benign, cervical deciduosis may macroscopically resemble malignant lesions, leading to diagnostic uncertainty. This report presents two cases of cervical deciduosis diagnosed in early pregnancy. Both patients presented with first-trimester vaginal bleeding, and speculum examination revealed extensive wart-like lesions covering the cervix. Histopathological examination of cervical biopsies confirmed decidual changes. In pregnant women presenting with threatened miscarriage, a thorough local examination and biopsy of atypical cervical lesions are essential to exclude malignancy. As cervical deciduosis is a benign and self-limiting condition, no further treatment is usually required.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"547-551"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We report a novel presentation of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) in a 9-year-old Moroccan male patient born to consanguineous parents, expanding the known clinical spectrum of the disease. The patient presented to a tertiary care hospital in Rabat, Morocco, in 2023. This case presents an unusual phenotype with early-onset epilepsy beginning at age 5, significantly broadening the known phenotypic spectrum of ARSACS. While initial neuroimaging was unremarkable, the patient exhibited classical retinal involvement with bilateral nerve fibre layer thickening. Genetic analysis revealed a previously unreported homozygous frameshift mutation in the SACS gene (c.12429delT), representing the first documented case in the Moroccan population. This observation extends both the understanding of ARSACS' clinical heterogeneity and its geographical distribution in North Africa. The patient responded favourably to antiepileptic treatment and physiotherapy which underscores the importance of early recognition and multidisciplinary management in atypical presentations. This case highlights the necessity of considering ARSACS in the differential diagnosis of early-onset ataxia with epilepsy, particularly in consanguineous populations.
{"title":"Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay with Early-Onset Epilepsy and Novel Clinical Features: <i>A rare entity from Morocco in the Middle East and North Africa region</i>.","authors":"Azzeddine Laaraje, Basma Alaoui, Abdelilah Radi, Amal Hasani, Aomar Agadr, Rachid Abilkassem","doi":"10.18295/2075-0528.2906","DOIUrl":"10.18295/2075-0528.2906","url":null,"abstract":"<p><p>We report a novel presentation of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) in a 9-year-old Moroccan male patient born to consanguineous parents, expanding the known clinical spectrum of the disease. The patient presented to a tertiary care hospital in Rabat, Morocco, in 2023. This case presents an unusual phenotype with early-onset epilepsy beginning at age 5, significantly broadening the known phenotypic spectrum of ARSACS. While initial neuroimaging was unremarkable, the patient exhibited classical retinal involvement with bilateral nerve fibre layer thickening. Genetic analysis revealed a previously unreported homozygous frameshift mutation in the <i>SACS</i> gene (c.12429delT), representing the first documented case in the Moroccan population. This observation extends both the understanding of ARSACS' clinical heterogeneity and its geographical distribution in North Africa. The patient responded favourably to antiepileptic treatment and physiotherapy which underscores the importance of early recognition and multidisciplinary management in atypical presentations. This case highlights the necessity of considering ARSACS in the differential diagnosis of early-onset ataxia with epilepsy, particularly in consanguineous populations.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"756-761"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-02eCollection Date: 2025-01-01DOI: 10.18295/2075-0528.2897
Almunqith Al-Abri, Reema Al-Majrafi, Ahmed Al-Maskari, Qasim Al-Mamari, Sunil K Nadar
Objectives: This study aimed to assess the incidence of erectile dysfunction (ED) in male patients with ischaemic heart disease (IHD) and to assess the psychological impact on these patients.
Methods: This questionnaire-based pilot study was conducted at the outpatient Cardiology Department of the Sultan Qaboos University Hospital, Muscat, Oman between January and December 2023. ED was assessed using the 5-item International Index of Erectile Function and the psychological state was assessed using the Depression Anxiety Stress Scale.
Results: A total of 100 patients were included in this study (mean age = 59.5 ± 10.4 years); 62 patients self-reported ED and 69 had some form of ED based on the questionnaire. Moderate to severe ED was found in 30 patients; these patients were older (66.7 ± 10.4 versus 56.4 ± 8.8; P <0.001), more likely to have hypertension (93.3% versus 65.7%; P = 0.004) and hyperlipidaemia (93.3% versus 70%; P = 0.01) and less likely to have undergone PCI (70% versus 88.6%; P = 0.02). There was no effect of drug therapy or other co-morbidities. By binary logistic regression, age was the only predictive factor for ED (odds ratio = 1.12, 95% confidence interval: 1.04-1.22; P = 0.003). Additionally, 32%, 14% and 13% had severe or very severe anxiety, stress and depression, respectively. The ED score corelated negatively and significantly with the anxiety score (r = -0.485; P <0.001), the stress score (r = -0.36; P <0.001) and depression score (r = -0.38; P <0.001).
Conclusion: This study found that ED is common in patients with IHD with significant psychological effects. Physicians should be aware of this while treating patients due to the effect on quality of life.
目的:本研究旨在评估男性缺血性心脏病(IHD)患者勃起功能障碍(ED)的发生率,并评估其对这些患者的心理影响。方法:这项基于问卷的试点研究于2023年1月至12月在阿曼马斯喀特苏丹卡布斯大学医院心脏病门诊部进行。ED采用5项国际勃起功能指数进行评估,心理状态采用抑郁焦虑压力量表进行评估。结果:共纳入100例患者(平均年龄59.5±10.4岁);62名患者自我报告ED, 69名患者根据调查问卷有某种形式的ED。中重度ED 30例;这些患者年龄较大(66.7±10.4比56.4±8.8,P = 0.004),高脂血症(93.3%比70%,P = 0.01),接受PCI治疗的可能性较小(70%比88.6%,P = 0.02)。没有药物治疗或其他合并症的影响。通过二元logistic回归,年龄是ED的唯一预测因素(优势比= 1.12,95%可信区间:1.04 ~ 1.22;P = 0.003)。此外,32%、14%和13%的人分别有严重或非常严重的焦虑、压力和抑郁。ED评分与焦虑评分呈显著负相关(r = -0.485; P P P P)结论:本研究发现,ED在IHD患者中较为常见,且心理影响显著。由于对患者生活质量的影响,医生在治疗患者时应该意识到这一点。
{"title":"Prevalence of Erectile Dysfunction and its Psychological Impact on Patients with Ischaemic Heart Disease in Oman.","authors":"Almunqith Al-Abri, Reema Al-Majrafi, Ahmed Al-Maskari, Qasim Al-Mamari, Sunil K Nadar","doi":"10.18295/2075-0528.2897","DOIUrl":"10.18295/2075-0528.2897","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the incidence of erectile dysfunction (ED) in male patients with ischaemic heart disease (IHD) and to assess the psychological impact on these patients.</p><p><strong>Methods: </strong>This questionnaire-based pilot study was conducted at the outpatient Cardiology Department of the Sultan Qaboos University Hospital, Muscat, Oman between January and December 2023. ED was assessed using the 5-item International Index of Erectile Function and the psychological state was assessed using the Depression Anxiety Stress Scale.</p><p><strong>Results: </strong>A total of 100 patients were included in this study (mean age = 59.5 ± 10.4 years); 62 patients self-reported ED and 69 had some form of ED based on the questionnaire. Moderate to severe ED was found in 30 patients; these patients were older (66.7 ± 10.4 versus 56.4 ± 8.8; <i>P</i> <0.001), more likely to have hypertension (93.3% versus 65.7%; <i>P</i> = 0.004) and hyperlipidaemia (93.3% versus 70%; <i>P</i> = 0.01) and less likely to have undergone PCI (70% versus 88.6%; <i>P</i> = 0.02). There was no effect of drug therapy or other co-morbidities. By binary logistic regression, age was the only predictive factor for ED (odds ratio = 1.12, 95% confidence interval: 1.04-1.22; <i>P</i> = 0.003). Additionally, 32%, 14% and 13% had severe or very severe anxiety, stress and depression, respectively. The ED score corelated negatively and significantly with the anxiety score (r = -0.485; <i>P</i> <0.001), the stress score (r = -0.36; <i>P</i> <0.001) and depression score (r = -0.38; <i>P</i> <0.001).</p><p><strong>Conclusion: </strong>This study found that ED is common in patients with IHD with significant psychological effects. Physicians should be aware of this while treating patients due to the effect on quality of life.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"784-791"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Unilateral pulmonary artery agenesis, typically affecting the right pulmonary artery, is a rare condition that may lead to congestive heart failure or pulmonary hypertension in infants and early surgical intervention improves outcomes. We report 5 cases from Muscat, Oman, of unilateral pulmonary artery agenesis who underwent surgical correction between November 2019 and August 2023, at an average age of 4.4 months. Most presented with cyanosis or respiratory distress and all had pulmonary hypertension confirmed by imaging. Surgical approaches included Gore-Tex conduit placement, autologous pericardial reconstruction and patent ductus arteriosus unifocalisation. All patients successfully restored pulmonary blood flow with no perioperative mortality. The median intensive unit care stay was 13 days and the median hospital stay was 20 days. Only 1 patient required repeat surgery for graft compression. Over a 27.6-month follow-up period, 4 patients showed regression of pulmonary hypertension and 2 underwent pulmonary angioplasty, reinforcing the benefits of timely intervention.
{"title":"Surgical Strategies for Unilateral Pulmonary Artery Agenesis: <i>A case series</i>.","authors":"Amr Abolwafa, Alaa Al-Lawati, Hamood Nasar Al-Kindi, Sunny Zacharias, Pranav Subbaraya Kandachar, Madan Mohan Maddali","doi":"10.18295/2075-0528.2951","DOIUrl":"10.18295/2075-0528.2951","url":null,"abstract":"<p><p>Unilateral pulmonary artery agenesis, typically affecting the right pulmonary artery, is a rare condition that may lead to congestive heart failure or pulmonary hypertension in infants and early surgical intervention improves outcomes. We report 5 cases from Muscat, Oman, of unilateral pulmonary artery agenesis who underwent surgical correction between November 2019 and August 2023, at an average age of 4.4 months. Most presented with cyanosis or respiratory distress and all had pulmonary hypertension confirmed by imaging. Surgical approaches included Gore-Tex conduit placement, autologous pericardial reconstruction and patent ductus arteriosus unifocalisation. All patients successfully restored pulmonary blood flow with no perioperative mortality. The median intensive unit care stay was 13 days and the median hospital stay was 20 days. Only 1 patient required repeat surgery for graft compression. Over a 27.6-month follow-up period, 4 patients showed regression of pulmonary hypertension and 2 underwent pulmonary angioplasty, reinforcing the benefits of timely intervention.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"26 1","pages":"13-19"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12797268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-02eCollection Date: 2025-01-01DOI: 10.18295/2075-0528.2928
[This corrects the article DOI: 10.18295/2075-0528.2907.].
[这更正了文章DOI: 10.18295/2075-0528.2907.]。
{"title":"Erratum: Mycoplasma pneumoniae-Induced Mucositis Sine Rash: <i>Case report in an adult patient</i>.","authors":"","doi":"10.18295/2075-0528.2928","DOIUrl":"10.18295/2075-0528.2928","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.18295/2075-0528.2907.].</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"938"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-02eCollection Date: 2025-01-01DOI: 10.18295/2075-0528.7458
Mohammed S Al Reesi, Moza Al Mamari, Sara Magzoub, Yasser AbdulRazek
Brain abscess in neonates is rare but remains a severe, life-threatening complication of meningitis with significant morbidity and mortality. While Citrobacter koseri and Citrobacter freundii are commonly implicated in brain-abscess formation, Citrobacter sedlakii is an uncommon causative pathogen. To date, only two cases of neonatal brain abscess caused by C. sedlakii have been reported in the literature. Early diagnosis, timely surgical intervention and prompt antibiotic therapy are critical to achieving a favourable outcome. A third case of a C. sedlakii brain abscess in a preterm infant, presenting in 2024 to a tertiary-care hospital in Oman, is reported together with a brief review of the literature.
{"title":"<i>Citrobacter Sedlakii</i> as a Rare Cause of Brain Abscess in a Late-Preterm Omani Infant: <i>Case report and literature review</i>.","authors":"Mohammed S Al Reesi, Moza Al Mamari, Sara Magzoub, Yasser AbdulRazek","doi":"10.18295/2075-0528.7458","DOIUrl":"10.18295/2075-0528.7458","url":null,"abstract":"<p><p>Brain abscess in neonates is rare but remains a severe, life-threatening complication of meningitis with significant morbidity and mortality. While <i>Citrobacter koseri</i> and <i>Citrobacter freundii</i> are commonly implicated in brain-abscess formation, <i>Citrobacter sedlakii</i> is an uncommon causative pathogen. To date, only two cases of neonatal brain abscess caused by <i>C. sedlakii</i> have been reported in the literature. Early diagnosis, timely surgical intervention and prompt antibiotic therapy are critical to achieving a favourable outcome. A third case of a <i>C. sedlakii</i> brain abscess in a preterm infant, presenting in 2024 to a tertiary-care hospital in Oman, is reported together with a brief review of the literature.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This review aimed to assess the prevalence of oncogenic and non-oncogenic viruses in odontogenic cysts and tumours. A comprehensive database search was performed for published articles regarding the presence of viruses in all odontogenic cysts and tumours, following guidelines without date constraints, and was registered with PROSPERO. After screening 164 articles, 24 studies were included for systematic evaluation. A meta-analysis was performed to determine the prevalence of human papillomavirus (HPV), revealing an overall pooled prevalence of HPV in ameloblastomas of 18.21% (95% confidence interval [CI]: 6.36-33.73) while the prevalence of HPV in odontogenic cysts was found to be 1.51% (95% CI: 0.00-9.46). The prevalence of Epstein-Barr virus in odontogenic tumours was 17.19% (95% CI: 4.62-34.49). Other viruses yielded varied results. Human carcinogenesis has previously been positively correlated with viruses; however, this systematic review's results indicate a very low prevalence in odontogenic pathoses and suggest a limited role in their aetiology.
{"title":"Prevalence of Viruses in Odontogenic Cysts and Tumours: <i>A systematic review of literature and meta-analysis</i>.","authors":"Deepak Pandiar, Divya Gopinath, Pinky Pavithran, Reshma Poothakulath Krishnan, Jishnu Krishna Kumar, Sajesh K Veettil","doi":"10.18295/2075-0528.2847","DOIUrl":"10.18295/2075-0528.2847","url":null,"abstract":"<p><p>This review aimed to assess the prevalence of oncogenic and non-oncogenic viruses in odontogenic cysts and tumours. A comprehensive database search was performed for published articles regarding the presence of viruses in all odontogenic cysts and tumours, following guidelines without date constraints, and was registered with PROSPERO. After screening 164 articles, 24 studies were included for systematic evaluation. A meta-analysis was performed to determine the prevalence of human papillomavirus (HPV), revealing an overall pooled prevalence of HPV in ameloblastomas of 18.21% (95% confidence interval [CI]: 6.36-33.73) while the prevalence of HPV in odontogenic cysts was found to be 1.51% (95% CI: 0.00-9.46). The prevalence of Epstein-Barr virus in odontogenic tumours was 17.19% (95% CI: 4.62-34.49). Other viruses yielded varied results. Human carcinogenesis has previously been positively correlated with viruses; however, this systematic review's results indicate a very low prevalence in odontogenic pathoses and suggest a limited role in their aetiology.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"370-381"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Symmetrical peripheral gangrene (SPG) is an exceptionally uncommon complication of malaria, predominantly linked with Plasmodium falciparum and mixed infections. We report a 41-year-old female who presented to a tertiary care centre of eastern India in 2022 with complaint of fever with chills and rigor for 4 days along with pain and acrocyanosis of distal portions of bilateral upper and lower limbs for last 2 days. Investigations revealed anaemia and neutrophilic leucocytosis with thrombocytopaenia. The peripheral smear revealed trophozoites of P. vivax and the malaria rapid diagnostic test confirmed the presence of P. vivax antigen. D-dimer and fibrin degradation product was elevated and prothrombin time and activated partial thromboplastin time were prolonged; arterial colour doppler of all 4 extremities were within normal limits. A diagnosis of P. vivax malaria was made complicated with disseminated intravascular coagulation leading to SPG.
{"title":"Symmetrical Peripheral Gangrene Associated with <i>Plasmodium Vivax</i> Malaria: <i>A case report with a brief review of literature</i>.","authors":"Atanu Chandra, Koustav A Shah, Debapratim Ganguly, Rupak Chatterjee, Sugata Dasgupta","doi":"10.18295/2075-0528.2842","DOIUrl":"10.18295/2075-0528.2842","url":null,"abstract":"<p><p>Symmetrical peripheral gangrene (SPG) is an exceptionally uncommon complication of malaria, predominantly linked with <i>Plasmodium falciparum</i> and mixed infections. We report a 41-year-old female who presented to a tertiary care centre of eastern India in 2022 with complaint of fever with chills and rigor for 4 days along with pain and acrocyanosis of distal portions of bilateral upper and lower limbs for last 2 days. Investigations revealed anaemia and neutrophilic leucocytosis with thrombocytopaenia. The peripheral smear revealed trophozoites of <i>P. vivax</i> and the malaria rapid diagnostic test confirmed the presence of <i>P. vivax</i> antigen. D-dimer and fibrin degradation product was elevated and prothrombin time and activated partial thromboplastin time were prolonged; arterial colour doppler of all 4 extremities were within normal limits. A diagnosis of <i>P. vivax</i> malaria was made complicated with disseminated intravascular coagulation leading to SPG.</p>","PeriodicalId":22083,"journal":{"name":"Sultan Qaboos University Medical Journal","volume":"25 1","pages":"336-340"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}